Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

ClinicalTrials.gov ID: NCT03089944

Public ClinicalTrials.gov record NCT03089944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3b, single arm, open-label, multicenter study in treatment naïve adults with chronic HCV infection and compensated cirrhosis to assess the safety of 8 weeks of treatment with glecaprevir/pibrentasvir and to demonstrate the efficacy of the sustained virologic response 12 weeks post dosing (SVR12) rates of 8 weeks of treatment with glecaprevir/pibrentasvir compared to the historical SVR12 rates of 12 weeks of treatment with glecaprevir/pibrentasvir.

Study identification

NCT ID
NCT03089944
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
343 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2017
Primary completion
Jul 30, 2019
Completion
Nov 7, 2019
Last update posted
Jul 12, 2020

2017 – 2019

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
St. Josephs Hosp and Med Ctr /ID# 162762 Phoenix Arizona 85013
Mayo Clinic Arizona /ID# 162314 Phoenix Arizona 85054
Liver Wellness Center /ID# 162244 Little Rock Arkansas 72204
Felizarta /ID# 162295 Bakersfield California 93301
VA Long Beach Healthcare System /ID# 162298 Long Beach California 90822
Usc /Id# 162248 Los Angeles California 90033
Kaiser Permanente - San Diego (Palm Ave) /ID# 162289 San Diego California 92154
Stanford University School of Med /ID# 162209 Stanford California 94305-2200
Cedars-Sinai Medical Center - West Hollywood /ID# 162313 West Hollywood California 90048
University of Miami /ID# 162210 Miami Florida 33136
Triple O Research Institute /ID# 162300 West Palm Beach Florida 33407-3100
Piedmont Hospital /ID# 162646 Atlanta Georgia 30309
Northwestern University Feinberg School of Medicine /ID# 162208 Chicago Illinois 60611-2927
Unity Point Health /ID# 162247 Des Moines Iowa 50309
The University of Iowa Hospita /ID# 162214 Iowa City Iowa 52242
University of Louisville /ID# 162242 Louisville Kentucky 40202
Louisiana Research Ctr. LLC /ID# 162567 Shreveport Louisiana 71105-6800
Mercy Medical Center /ID# 162291 Baltimore Maryland 21202
Mayo Clinic - Rochester /ID# 162251 Rochester Minnesota 55905-0001
Southern Therapy and Advanced Research (STAR) LLC /ID# 162241 Jackson Mississippi 39216
CHI Health Alegent Creighton /ID# 162286 Omaha Nebraska 68124
Univ Nebraska Med Ctr /ID# 162285 Omaha Nebraska 68198
Rnjms /Id# 162213 Newark New Jersey 07103
Weill Cornell Medical College /ID# 161051 New York New York 10021
Icahn School of Med Mt. Sinai /ID# 162294 New York New York 10029
Montefiore Medical Center /ID# 162312 The Bronx New York 10461
James J. Peters VA Medical Center /ID# 162644 The Bronx New York 10468
Duke University Medical Center /ID# 162299 Durham North Carolina 27710-3000
Cumberland Research Assoc /ID# 162212 Fayetteville North Carolina 28304
Carolinas Center for Liver Dis /ID# 162569 Statesville North Carolina 28677-3471
University Hospitals Cleveland /ID# 162243 Cleveland Ohio 44106
Cleveland Clinic /ID# 162570 Cleveland Ohio 44111
Osuchs /Id# 162284 Tulsa Oklahoma 74127
Lehigh Valley Health Network /ID# 162603 Allentown Pennsylvania 18103
Center for Liver Diseases, Oakland /ID# 162568 Pittsburgh Pennsylvania 15213
Vanderbilt Univ Med Ctr /ID# 162211 Nashville Tennessee 37232-0011
Texas Digestive Disease Consul /ID# 162648 Dallas Texas 75246-1613
University of Texas Health /ID# 162288 Houston Texas 77030-1501
Virginia Commonwealth Univ /ID# 162215 Richmond Virginia 23219
Univ of Wisconsin Hosp/Clinics /ID# 162645 Madison Wisconsin 53792-0001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03089944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2020 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03089944 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →